Category: California
|
|
| |
|
California Life Science Firms to Learn "Insider" Strategies for Government Funding at 11th SoCalBio Investor & Partnership Conference
|
 |
Date: April 22, 2010
Time: 9:00AM-4:00PM
Venue: San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
Application Cost: free
Registration Cost: from $150 to $175
Emerging companies find it increasingly difficult to reach the right person when seeking funding. It is equally difficult for companies with funds to allocate to wade through countless proposals in search of the right opportunity that aligns with their investment strategy and in some cases their mission. Through the “Meet with…” Series, we provide emerging life science companies with greater access to partnering and/or financing opportunities. Attendees must apply and be approved to attend. To apply, please send your Executive Summary to Aurélie at aurelie@sjbiocenter.com. The Review Board, composed of the BioCenter management team, sponsors, partners and mentors, will then meet to consider your application. | Application fee: free | Registration fee: from $150 to $175 | 9:00-4:00 | @ the San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
 |
|
Slicing the Pie: Entity Formation and the Division of Equity
|
|
qed@qb3 - UCB
Friday, March 5, 2010
12:00 to 1:00 pm
Stanley Hall Room 621
|
Matt Kirmayer will lead a discussion of the issues relating to forming an entity, seeding it with the assets and IP to be successful, and avoiding the potential pitfalls when dividing up the equity among the founders.
Matt Kirmayer is a member in the Corporate practice. His practice is focused on the representation of emerging technology companies, venture capital and private equity funds and institutional investors. Matt represents clients in many industries, such as multimedia, wireless technologies, networking, internet infrastructure and security, nanotechnology, life sciences and medical devices. He also represents NY Money Center Banks and institutional investors in capital market transactions. Prior to joining Mintz Levin, Matt was a partner at a San Francisco area law firm. Matt began his career in New York City handling securities offerings and merger and acquisition transactions. Matt is admitted to practice law in California and New York. He received a J.D. from Rutgers University and an LL.M. from New York University School of Law.
Lunch provided, but space is limited so please reserve a seat here.
http://qb3.org/services/qed-qb3/?searchterm=qed
Date: June 23, 2010
Time: 9:00AM-4:00PM
Venue: San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
Application Cost: free
Registration Cost: from $150 to $175
Through the “Meet with…” Series, we provide you with greater access to partnering and financing opportunities. In this session, members of Gilead will talk to potential licensees to first explain what they are looking for in a company. After the presentation, attendees will have lunch with the Gilead team. Finally, each pre-approved attendee* will be granted a private meeting with a member of the Gilead team. *Attendees must apply and be approved to attend the one-on-one meetings. To apply, please send your Executive Summary to aurelie@sjbiocenter.com. The Review Board, composed of the BioCenter management team, sponsors, partners and mentors, will then meet to consider your application. | Application fee: free | Registration fee: from $150 to $175 | 9:00-4:00 | @ the San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
 |
|
...But what do I know?
Lessons learned from living through a couple of spin-out companies
|
|
qed@qb3 UCSF
Thursday, March 4, 2010
12:00 to 1:00 pm
Byers Hall Room 212
|
There are many lessons to be learned in the formation of spinouts. Tom will walk through his experiences going from an academic setting to a spinout company and what he has learned from this and a couple of other companies that he has been close to (Avantome, TrueMaterials, Boreal Genomics)
Tom Willis is the CEO of MLC Dx Inc. a VC backed company dedicated to the commercialization of molecular diagnostic tests. Prior to founding MLC, Tom has been an entrepreneur in the biotech industry for the past decade. After receiving his Ph.D. in physics from Stanford University, he joined the Stanford Genome Technology Center (SGTC) to work on DNA sequence analysis technologies. He held several positions at the SGTC including Associate Director in charge of technology development. While at SGTC, he co-invented the Molecular Inversion Probe technology for high throughput genotyping. In 2001, he co-founded ParAllele BioScience to develop and commercialize this technology. As its founding CEO, he led ParAllele through two rounds of VC financing a grew the company to over 80 employees. In 2005 ParAllele was acquired by Affymetrix at which time Tom served in several management positions at Affymetrix. He left in 2007 to pursue new startup opportunities. In addition to his role at MLC, Tom serves on the boards of SpinX Technologies and Boreal Genomics
Lunch provided, but space is limited so please reserve a seat at http://www.acteva.com/booking.cfm?bevaID=198455
http://qb3.org/services/qed-qb3/?searchterm=qed
Date: March 25, 2010
Time: 3:00PM-6:30PM
Venue: Orrick, Herrington & Sutcliffe LLP, 1000 Marsh Road, Menlo Park CA 94025-1015
Registration Cost: from $0 to $70
Effectively raising capital is crucial for any company. Sufficient capital helps ensuring R&D, Due Diligence, Legal and Accounting services, Marketing, and improves hiring potential. In this session, a panel of VCs and CEOs will deliver the tips and tricks to realizing a successful financing process.
Questions that will be raised include: • What are the steps to prepare for a financing round? • What are the strategies for attracting, securing and structuring financing deals? • Is there a valuation best practice for an emerging company in this complex environment? • When to start your financing round, and when not to?
Our Panel discussions are candid, interactive and informal. We want you to walk away with the real story behind how things work so you can make it happen yourself. This Panel will be followed by a Networking Reception. | Registration fee: from $0 to $70 | 3:00-6:30 | @ Orrick, Herrington & Sutcliffe LLP, 1000 Marsh Road, Building 1100, Menlo Park CA 94025-1015
|
|
Risk Management and Insurance Primer for Life Science Companies
|
|
qed@qb3 - Special Event
Tuesday, February 23, 2010
12:00 to 1:00 pm
Byers Hall Room 212
|
In this discussion we will touch on the various aspects and stages of Risk Management and Insurance for Life Science Companies from start-up, through clinical trials to product commercialization. The primer will touch on all aspects of insurance from workers' compensation, property and general liability, to clinical trials, international, directors and officers and more.
Kevin Mirsky is a Principal of Saylor & Hill Co. and has been with the firm since 1991. Kevin leads Saylor & Hill Co.'s Technology and Life Science Practice in the Bay Area, providing Risk Assessment and Insurance Brokerage services to mid- and large-size clients. He has expertise in multi-national clinical trials, medical device and pharmaceutical products as well as software, hardware and web-based businesses. Kevin is active in the community, and is a member of BayBio.
Lunch provided, but space is limited so please reserve a seat at http://www.acteva.com/booking.cfm?bevaID=198053
Date: March 2, 2010
Time: 12:00PM-2:00PM
Venue: San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
Registration Cost: from $0 to $40
The achievement of a cleared Investigational New Drug application (IND) is a critical milestone for most small to mid-sized companies. Senior Management teams face many challenges when working on these applications. These are not easy applications to create, and there are many potential pitfalls. During this presentation the pitfalls that CEOs and senior management teams need to be aware of will be identified. A panel session will follow the main presentation at which time the audience will be able to address questions to members of the panel. Webinar link-up is available for those who are not able to participate on-site. Please indicate if you would like to join by webinar when signing up. The details for the webinar will be sent to participants before the event. | Registration fee: from $0 to $40 | 12:00-2:00 | @ the San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
Speakers: Debra Gosling, Account Executive, Regulatory & Clinical Services, Liquent Inc. | Tom Delisi, Senior Consultant, Regulatory Services, Liquent Inc. | Kathryn Plank, Senior Regulatory Consultant, Liquent Inc. | Jim Hilferty, Operations Manager, Regulatory & Clinical Services, Liquent Inc.
|
|
Building, Compensating & Motivating
a Leadership Team
|
|
qed@qb3 - UCSF
Thursday, February 4, 2010
12:00 to 1:00 pm
Byers Hall Room 212
|
One of the most critical factors for a company's success is building an excellent team, but finding, recruiting, compensating, and ultimately motivating the best people is extremely challenging. Chris McKinley and Michael Ballenger bring decades of HR and executive recruitment experience to this subject and will share their insights and advice in this seminar.
Christine McKinley has 30 years experience working in entrepreneurial, high growth biotech and medical companies. Prior to founding Round One Resources, she was Sr.VP of Human Resources at Cell Genesys, responsible for strategic and operational HR initiatives, involving extensive staffing of a manufacturing facility, expansion of process development, manufacturing and clinical operations, merger, acquisition and restructuring activities. She began as one of the earlier employees of Genentech.
Michael Ballenger specializes in Board of Director, CEO searches as well as officer-level assignments in research, product development and all business functions. He has 23 years of experience in executive search in all segments of the life science/healthcare product industry and has focused his last 10 years on work with start-up and development stage companies. He was previously the Managing Partner of Highland Partner's San Francisco office where he built the company's first Life Science/Healthcare Products Practice and was also Sr. Director of Human Resources for Genentech.
Lunch provided, but space is limited so please reserve a seat at http://www.acteva.com/booking.cfm?bevaID=197756
Date: February 3, 2010
Time: 2:30PM-3:30PM
Venue: San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
Registration Cost: free
The Open House Tour is an opportunity for anyone interested in the BioCenter to tour the facility and the Core Labs, to meet the management, and learn more about the BioCenter history and its clients. The Tour starts at 2:30 and lasts around an hour depending on attendance and how curious you are! | Registration fee: free | 2:30-3:30 | @ the San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
